TrialHuman reproduction (Oxford, England)2024

Two-year efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT open-label extension study.

Christian M Becker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.